DuPont de Nemours, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data DuPont de Nemours, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	48,158	62,484	22,594	21,512	20,397	12,566	13,017	6,614	6,719	6,849
Cost of revenue	37,668	9,558	15,302	10,026	7,063	7,971	8,402	4,442	4,499	4,486
Gross profit	10,518	12,693	20,644	11,486	13,334	4,595	4,615	2,172	2,220	2,363
Research and development	1,593	657	1,070	689	565	557	536	192	203	193
Selling, general and administrative	2,953	1,615	3,028	2,057	1,492	1,602	1,467	891	976	1,019
Interest expense	858	0	55	667	672	525	492	396	366	313
Interest income	107	6	39	56	18	12	50	155	74	98
Other non-operating income	1,486	66	92	144	632	145	191	80	-111	14
Pre-tax income	4,413	-1,525	600	-126	-1,259	1,444	1,448	-279	117	200
Income tax	9	-1,758	195	-2	90	237	387	-217	213	102
Net income to minority interests	86	132	155	102	28	48	49	39	35	41
Net income	4,318	1,159	3,845	498	-2,951	6,467	5,868	423	703	-779
EPS, basic	8.43	2.18	4.99	0.67	-4.01	11.92	11.77	0.94	1.68	-1.87
EPS, diluted	8.32	2.15	4.96	0.67	-4.01	11.89	11.75	0.94	1.68	-1.86
Shares, basic (weighted)	469	527	767	746	736	543	499	450	419	418
Shares, diluted (weighted)	475	533	772	746	736	544	499	450	419	419
Dividend per share	4.35	5.28	4.56	2.16	1.20	1.20	1.32	1.44	1.52	1.43

Balance sheet

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	6,607	13,438	8,548	1,540	2,544	1,972	3,662	2,392	1,792	715
Short-term investments	0	956	29	0		0	1,302	0
Receivables	4,666	11,314	2,891	2,954	1,850	1,612	1,567	1,513	789	910
Inventory	7,363	16,992	4,107	4,319	2,393	2,086	2,329	2,147	1,130	1,172
Other current assets	711	1,614	305	338	181	177	161	194	125	121
Total current assets	23,659	49,893	126,655	9,999	29,008	14,303	11,270	7,514	20,775	5,575
Property, plant and equipment	23,486	36,247	9,917	10,143	6,867	5,753	5,731	5,884	3,454	3,464
Lease right-of-use assets				556	423	422	426	484	251	209
Goodwill	15,272	34,820	34,496	22,139	16,040	16,981	16,663	7,657	7,561	7,915
Intangible assets	6,026	33,274	14,655	13,593	8,072	6,222	5,495	5,814	3,178	2,936
Long-term investments	1,253	1,372	1,683
Other non-current assets	565	2,774	134	1,014	812	1,360	1,251	1,237	977	971
Total assets	79,511	191,907	187,855	69,349	70,903	45,707	41,355	38,552	36,636	21,575
Accounts payable	4,519	9,134	2,619	2,934	2,222	2,102	2,103	1,675	1,054	995
Accrued liabilities	4,481	8,409	1,129	1,342	1,084	1,040	951	1,269	784	882
Deferred revenue		2,131	71	20	16	25	11	1	2
Short-term debt	635	2,067	15	3,830	1	150	300	0	1,848	60
Total current liabilities	12,604	26,128	73,312	8,346	12,226	4,931	3,733	3,098	5,496	2,305
Long-term debt	20,456	30,056	12,624	13,617	15,611	10,632	7,774	7,800	5,323	3,134
Lease liabilities				416	308	337	333	390	205	165
Other non-current liabilities	5,560	7,969	764	1,191	834	873	1,151	1,234	1,068	1,196
Total liabilities	52,261	90,517	91,955	27,793	31,834	18,657	14,338	13,827	12,843	7,472
Total debt	21,091	32,123	-12,635	-15,618	15,612	10,632	8,145	7,859	1,848	0
Paid-in capital	4,262	81,257	81,976	50,796	50,039	49,574	48,420	48,059	47,922	38,721
Retained earnings	30,338	29,211	30,257	-8,400	-11,586	-23,187	-21,065	-22,874	-23,076	-24,278
Treasury stock	-1,659	-1,000	-5,421	0
Other comprehensive income	-9,822	-8,972	-12,394	-1,416	44	41	-791	-910	-1,500	-525
Shareholders' equity	25,987	100,330	94,292	40,987	38,504	26,433	26,569	24,279	23,350	13,919
Minority interests	1,242	1,597	1,608	569	566	617	448	446	443	184
Total equity	27,250	101,647	95,900	41,556	39,070	27,050	27,017	24,725	23,793	14,103
Total liabilities and equity	79,511	192,164	187,855	69,349	70,904	45,707	41,355	38,552	36,636	21,575
Shares outstanding		780	784	739	734

Cash flow statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	4,404	1,291	4,000	600	-2,923	6,515	5,917	462	738	-738
Depreciation and amortization	2,862	1,060	2,170	3,195	3,094	1,112	1,135	580	635	647
Stock-based compensation	261	19	92	87	93	67	75	57	56	38
Deferred income tax	-1,259	-1,473	-667	-467	-268	-259	-204	-308	-92	13
Change in inventory		-9,629
Change in payables	569	2,631	201	-1,049	177	221	-138	-232	-36	61
Cash from operations	-2,957	-765	4,731	1,409	4,095	2,281	588	845	765	560
Capital expenditures	-3,804	-551	-1,244	-2,472	-1,194	-788	-662	-302	-285	-333
Acquisitions	-187	50	-20	-180	-70	-2,346	5	-1,761	-313	-55
Purchases of investments	-577	-1,690	-2,787	-197	-1	-2,001	-1,317	-32	0	0
Sales and maturities of investments	396	245	1,053	242	1	2,001	15	1,334	0	0
Cash from investing	5,092	14,325	-2,462	-2,313	-202	-2,401	8,923	481	-562	-374
Debt repaid								-300	-687	-4,134
Stock issued	0	66	197	85	57	115	88	27	50	32
Share buybacks	-916	-1,000	-4,421	-2,329	-232	-2,143
Dividends paid	-2,462	-3,394	-3,491	-1,611	-882	-630	-652	-651	-635	-597
Cash from financing	-4,014	-6,554	-1,918	-11,550	3,238	-6,507	-7,667	-2,956	-1,826	-1,750
Exchange rate effect	-77	297	-344
Net change in cash	-1,956	7,391	7	-12,445	7,198	-6,699	1,696	-968	-911	-1,132
Free cash flow	-6,761	-1,316	3,487	-1,063	2,901	1,493	-74	543	480	227
Interest paid	1,192	1,254	2,116	969	647	498	494
Income taxes paid	1,592	1,368	2,199	722	495	561	829	168	184	127

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $131.71 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	35.1%	Gross profit / revenue.
Pre-tax margin	6.8%	Pre-tax income / revenue.
Net margin	0.8%	Net income / revenue.
FCF margin	10.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	14.9%	Cash from operations / revenue.
Effective tax rate	7.6%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	0.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.3%	Net income / average total assets.
R&D / revenue	0.3%	Research and development expense / revenue.
SG&A / revenue	11.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	4.9%	Capital expenditures / revenue.
D&A / revenue	6.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	1.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-19.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-19.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	6.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-20.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-29.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-210.8%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-210.7%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-26.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-1.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-32.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-52.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-39.9%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	-5.9%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	2.7%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	3.6%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-40.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-19.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-18.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-41.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-19.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-21.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-5.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-10.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.43x	Current assets / current liabilities.
Quick ratio	1.74x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.87x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.00x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	0.0%	Total debt / total assets.
Liabilities / assets	34.1%	Total liabilities / total assets.
Net debt	-$1.74B	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$2.86B	Current assets - current liabilities.
Goodwill and intangibles / assets	50.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	$3.14B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.33x	Revenue / average total assets.
Fixed asset turnover	2.07x	Revenue / average property, plant and equipment.
Inventory turnover	3.75x	Cost of revenue / average inventory.
Days inventory	97 days	365 x average inventory / cost of revenue.
Receivables turnover	3.99x	Revenue / average receivables.
Days sales outstanding	91 days	365 x average receivables / revenue.
Days payables	79 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	110 days	Days inventory + days sales outstanding - days payables.
FCF conversion	1,276.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	32.6%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.85	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$51.08	Revenue / diluted weighted shares.
FCF per share	$5.13	Free cash flow / diluted weighted shares.
Operating cash flow per share	$7.61	Cash from operations / diluted weighted shares.
Book value per share	$100.65	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$22.95	Tangible book value / shares outstanding.
Cash per share	$12.72	(Cash + short-term investments) / shares outstanding.
Payout ratio	758.2%	Dividends paid / net income, when net income is positive.
Dividends / FCF	59.4%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$17.79B	Share price x shares outstanding.
Enterprise value	$16.05B	Market cap + total debt - cash - short-term investments.
P/E	323x	Market cap / net income. Only when net income is positive.
P/S	2.55x	Market cap / revenue.
P/B	1.29x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	5.66x	Market cap / tangible book value, when positive.
P/FCF	25.3x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	17.1x	Market cap / cash from operations, when positive.
EV/Sales	2.30x	Enterprise value / revenue.
EV/FCF	22.9x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.9%	Free cash flow / market cap.
Earnings yield	0.3%	Net income / market cap (the inverse of P/E).
Dividend yield	2.3%	Dividends paid over the period / market cap.
Shareholder yield	2.3%	(Dividends paid + share buybacks) / market cap.

What was DuPont de Nemours, Inc.'s revenue in fiscal 2025?

DuPont de Nemours, Inc. reported revenue of $6.85B for fiscal 2025, 1.9% higher than the year before.

Was DuPont de Nemours, Inc. profitable in fiscal 2025?

No. It reported a net loss of $779.0M.

How much free cash flow did DuPont de Nemours, Inc. generate in fiscal 2025?

Cash from operations of $560.0M minus capital expenditures of $333.0M left free cash flow of $227.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to DuPont de Nemours, Inc.